Rock Springs Capital Management LP Amgen Inc Transaction History

Rock Springs Capital Management LP

  • $2.94 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$255.7 - $288.46 $1.66 Million - $1.87 Million
6,500 Added 9.56%
74,500 $21.5 Million
Q3 2023

Nov 14, 2023
BUY
$218.65 - $271.46 $14.9 Million - $18.5 Million
68,000 New
68,000 $18.3 Million
Q3 2020

Nov 16, 2020
SELL
$234.65 - $260.95 $29.6 Million - $32.9 Million
-126,000 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$174.11 - $208.62 $21.9 Million - $26.3 Million
126,000 New
126,000 $24.4 Million

Others Institutions Holding AMGN

# of Institutions
3,123
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email